{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:16:26Z","timestamp":1790104586398,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ecotec University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-04940-w","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:34:15Z","timestamp":1773794055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Co-occurrence of blaKPC and blaOXA\u221248 genes in Klebsiella pneumoniae isolates from a tertiary-care hospital in Ecuador and evidence of emerging genotypic\u2013phenotypic AMR inconsistencies"],"prefix":"10.1186","volume":"26","author":[{"given":"David","family":"Fern\u00e1ndez-Salvatierra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Mar\u00eda","family":"Gonz\u00e1lez-Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Morey-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Fern\u00e1ndez-Cadena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"4940_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355.","journal-title":"Lancet"},{"key":"4940_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404:1199\u2013226.","journal-title":"Lancet"},{"key":"4940_CR3","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/S0140-6736(24)01076-6","volume":"403","author":"The Lancet","year":"2024","unstructured":"The Lancet. Antimicrobial resistance: an agenda for all. Lancet. 2024;403:2349.","journal-title":"Lancet"},{"key":"4940_CR4","doi-asserted-by":"publisher","first-page":"100082","DOI":"10.1016\/j.soh.2024.100082","volume":"3","author":"MEJ Woolhouse","year":"2024","unstructured":"Woolhouse MEJ. One Health approaches to tackling antimicrobial resistance. Sci One Health. 2024;3:100082. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949704324000210.","journal-title":"Sci One Health"},{"key":"4940_CR5","doi-asserted-by":"publisher","first-page":"0001333","DOI":"10.1099\/mic.0.001333","volume":"169","author":"A Gaurav","year":"2023","unstructured":"Gaurav A, Bakht P, Saini M, Pandey S, Pathania R. Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors. Microbiology. 2023;169:0001333.","journal-title":"Microbiology"},{"key":"4940_CR6","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.gmg.2025.100042","volume":"12","author":"KE Vivekanandan","year":"2025","unstructured":"Vivekanandan KE, Kumar PV, Jaysree RC, Rajeshwari T. Exploring molecular mechanisms of drug resistance in bacteria and progressions in CRISPR\/Cas9-based genome expurgation solutions. Glob Med Genet. 2025;12:100042.","journal-title":"Glob Med Genet"},{"key":"4940_CR7","doi-asserted-by":"publisher","first-page":"105459","DOI":"10.1016\/j.meegid.2023.105459","volume":"112","author":"MN Hajiagha","year":"2023","unstructured":"Hajiagha MN, Kafil HS. Efflux pumps and microbial biofilm formation. Infect Genet Evol. 2023;112:105459.","journal-title":"Infect Genet Evol"},{"key":"4940_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","volume":"21","author":"EM Darby","year":"2023","unstructured":"Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, et al. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2023;21:280\u201395.","journal-title":"Nat Rev Microbiol"},{"key":"4940_CR9","doi-asserted-by":"publisher","first-page":"dlab092","DOI":"10.1093\/jacamr\/dlab092","volume":"3","author":"M Castanheira","year":"2021","unstructured":"Castanheira M, Simner PJ, Bradford PA. Extended-spectrum \u03b2-lactamases: an update on their characteristics, epidemiology and detection. JAC Antimicrob Resist. 2021;3:dlab092.","journal-title":"JAC Antimicrob Resist"},{"key":"4940_CR10","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/biomedicines11112937","volume":"11","author":"A Husna","year":"2023","unstructured":"Husna A, Rahman MM, Badruzzaman ATM, Sikder MH, Islam MR, Rahman MT, et al. Extended-Spectrum \u03b2-Lactamases (ESBL): Challenges and Opportunities. Biomedicines. 2023;11:2937.","journal-title":"Biomedicines"},{"key":"4940_CR11","doi-asserted-by":"publisher","first-page":"e02889","DOI":"10.1128\/mbio.02889-23","volume":"15","author":"LY Lai","year":"2024","unstructured":"Lai LY, Satishkumar N, Cardozo S, Hemmadi V, Marques LB, Huang L, et al. Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum \u03b2-lactam resistance in Staphylococcus aureus. mBio. 2024;15:e02889\u201323.","journal-title":"mBio"},{"key":"4940_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.33314\/jnhrc.v21i4.4861","volume":"21","author":"L Ghimire","year":"2024","unstructured":"Ghimire L, Banjara MR, Abdulla AM. Antibiotic Susceptibility of Staphylococcus Aureus with vanA and mecA Genes. J Nepal Health Res Counc. 2024;21:616\u201322.","journal-title":"J Nepal Health Res Counc"},{"key":"4940_CR13","doi-asserted-by":"crossref","unstructured":"Maharjan M, Sah AK, Pyakurel S, Thapa S, Maharjan S, Adhikari N et al. Molecular Confirmation of Vancomycin-Resistant Staphylococcus aureus with vanA Gene from a Hospital in Kathmandu. Int. J. Microbiol. 2021;2021:1\u20138.","DOI":"10.1155\/2021\/3847347"},{"key":"4940_CR14","doi-asserted-by":"publisher","unstructured":"Smith JT, Eckhardt EM, Hansel NB, Rahmani Eliato T, Martin IW, Andam CP. Genome Evolution of Invasive Methicillin-Resistant Staphylococcus aureus in the Americas. Microbiol Spectr. 2022;10:e00201\u201322. https:\/\/doi.org\/10.1128\/spectrum.00201-22.","DOI":"10.1128\/spectrum.00201-22"},{"key":"4940_CR15","doi-asserted-by":"publisher","first-page":"12366","DOI":"10.3389\/bjbs.2024.12366","volume":"81","author":"SJ Pitt","year":"2024","unstructured":"Pitt SJ, Gunn A. The One Health Concept. Br J Biomed Sci. 2024;81:12366.","journal-title":"Br J Biomed Sci"},{"key":"4940_CR16","unstructured":"Centers for Disease Control and Prevention (CDC). Antimicrobial Resistance: Causes and How It Spreads. CDC; 2024. https:\/\/www.cdc.gov\/antimicrobial-resistance\/causes\/index.html#:~:text=Antimicrobial%2Dresistant%20germs%20can%20share,or%20even%20impossible%2C%20to%20treat."},{"key":"4940_CR17","first-page":"1","volume-title":"One Health Joint Plan of Action (2022\u20132026): Working Together for the Health of Humans, Animals, Plants and the Environment","author":"the World Health Organization (WHO)","year":"2022","unstructured":"the World Health Organization (WHO). ), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and. One Health Joint Plan of Action (2022\u20132026): Working Together for the Health of Humans, Animals, Plants and the Environment. 1st ed. Geneva: World Health Organization; 2022. p. 1.","edition":"1"},{"key":"4940_CR18","first-page":"20180332","volume":"285","author":"EK Rousham","year":"2018","unstructured":"Rousham EK, Unicomb L, Islam MA. Human, animal and environmental contributors to antibiotic resistance in low-resource settings: integrating behavioural, epidemiological and One Health approaches. Proc Biol Sci. 2018;285:20180332.","journal-title":"Proc Biol Sci"},{"key":"4940_CR19","doi-asserted-by":"publisher","first-page":"100902","DOI":"10.1016\/S2666-5247(24)00134-4","volume":"5","author":"S Bertagnolio","year":"2024","unstructured":"Bertagnolio S, Dobreva Z, Centner CM, Olaru ID, Don\u00e0 D, Burzo S, et al. WHO global research priorities for antimicrobial resistance in human health. Lancet Microbe. 2024;5:100902.","journal-title":"Lancet Microbe"},{"key":"4940_CR20","doi-asserted-by":"publisher","first-page":"e3000250","DOI":"10.1371\/journal.pbio.3000250","volume":"17","author":"D McAdams","year":"2019","unstructured":"McAdams D, Wollein Waldetoft K, Tedijanto C, Lipsitch M, Brown SP. Resistance diagnostics as a public health tool to combat antibiotic resistance: A model-based evaluation. PLoS Biol. 2019;17:e3000250.","journal-title":"PLoS Biol"},{"key":"4940_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/antibiotics9070372","volume":"9","author":"K Iskandar","year":"2020","unstructured":"Iskandar K, Molinier L, Hallit S, Sartelli M, Catena F, Coccolini F, et al. Drivers of Antibiotic Resistance Transmission in Low- and Middle-Income Countries from a One Health Perspective-A Review. Antibiotics. 2020;9:372.","journal-title":"Antibiotics"},{"key":"4940_CR22","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3855\/jidc.18945","volume":"18","author":"S Hussain","year":"2024","unstructured":"Hussain S, Sultan S, Riaz S, Hussain H, Javed H, Mazhar R. Synergy of Xpert (MTB\/RIF) and Line probe assay for detection of rifampicin-resistant strains of Mycobacterium tuberculosis. J Infect Dev Ctries. 2024;18:1241\u20138.","journal-title":"J Infect Dev Ctries"},{"key":"4940_CR23","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Alom\u00eda F, Bastidas-Caldes C, Ballesteros I, Tenea GN, Molina J-VP et al. CA,. Beta-Lactam Antibiotic Resistance Genes in the Microbiome of the Public Transport System of Quito, Ecuador. IJERPH. 2023;20:1900.","DOI":"10.3390\/ijerph20031900"},{"key":"4940_CR24","doi-asserted-by":"publisher","first-page":"e00542","DOI":"10.1128\/spectrum.00542-24","volume":"12","author":"D Vatterrodt","year":"2024","unstructured":"Vatterrodt D, Lee J, Ho D, Stevig C, Chow SK. Misidentification and misreporting of antibiotic resistance in Kluyvera bacteremia by blood culture molecular identification panels. Microbiol Spectr. 2024;12:e00542\u201324.","journal-title":"Microbiol Spectr"},{"key":"4940_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-9849-4_2","volume":"2069","author":"EL Palavecino","year":"2020","unstructured":"Palavecino EL. Rapid Methods for Detection of MRSA in Clinical Specimens. Methods Mol Biol. 2020;2069:29\u201345.","journal-title":"Methods Mol Biol"},{"key":"4940_CR26","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3109\/21691401.2015.1041639","volume":"44","author":"MR Shahmohammadi","year":"2016","unstructured":"Shahmohammadi MR, Nahaei MR, Akbarzadeh A, Milani M. Clinical test to detect mecA and antibiotic resistance in Staphylococcus aureus, based on novel biotechnological methods. Artif Cells Nanomed Biotechnol. 2016;44:1464\u20138.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"4940_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.26807\/remcb.v30i1-2.70","volume":"30","author":"D Ortega","year":"2009","unstructured":"Ortega D, Alcocer I, Zurita J. Alta prevalencia de enzimas modificadoras de aminogluc\u00f3sidos (EMAs) en aislados cl\u00ednicos de Klebsiella pneumoniae (KPN) productores de \u03b2-lactamasas de espectro extendido (BLEE). REMCB. 2009;30:16\u201327.","journal-title":"REMCB"},{"key":"4940_CR28","doi-asserted-by":"crossref","unstructured":"\u00d6zyazici G, \u00d6zkaya E, Kaya H, Kocat\u00fcrk Sel S, Altinba\u015fak H, Ba\u015fari F et al. Investigation of blaKPC Gene by PCR in Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae Clinical \u0130solates in a Tertiary Care Hospital in Turkey. MJIMA. 2019;8:3.","DOI":"10.4274\/mjima.galenos.2019.2019.3"},{"key":"4940_CR29","doi-asserted-by":"publisher","first-page":"e20180460","DOI":"10.1590\/0037-8682-0460-2018","volume":"52","author":"EF Firmo","year":"2019","unstructured":"Firmo EF, Cabral AB, de Oliveira \u00c9M, Lopes ACS. Emergence of aph(3\u2019)-VI and accumulation of aminoglycoside-modifying enzyme genes in KPC-2-possessing Enterobacter aerogenes isolates from infections and colonization in patients from Recife-PE, Brazil. Rev Soc Bras Med Trop. 2019;52:e20180460.","journal-title":"Rev Soc Bras Med Trop"},{"key":"4940_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fcimb.2020.00314","volume":"10","author":"R Han","year":"2020","unstructured":"Han R, Shi Q, Wu S, Yin D, Peng M, Dong D, et al. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated from Adult and Children Patients in China. Front Cell Infect Microbiol. 2020;10:314.","journal-title":"Front Cell Infect Microbiol"},{"key":"4940_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/14787210.2020.1813023","volume":"19","author":"JC Garc\u00eda-Betancur","year":"2021","unstructured":"Garc\u00eda-Betancur JC, Appel TM, Esparza G, Gales AC, Levy-Hara G, Cornistein W, et al. Update on the epidemiology of carbapenemases in Latin America and the Caribbean. Expert Rev Anti Infect Ther. 2021;19:197\u2013213.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4940_CR32","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-P\u00e9rez AU, Madruga-Fern\u00e1ndez M, de la Hern\u00e1ndez-S\u00e1nchez C. MC. Enterobacterales that produce betalactamases in clinical isolations of hospitalized patients inside an institution of secondary medical level. Havana - CUBA 2021 REM HRL. 2022;8(3). http:\/\/www.rem.hrlamb.gob.pe\/index.php\/REM\/article\/view\/614","DOI":"10.37065\/rem.v8i3.614"},{"key":"4940_CR33","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.22207\/JPAM.16.4.08","volume":"16","author":"S Abhishek","year":"2022","unstructured":"Abhishek S. Genotypic Distribution and Antimicrobial Susceptibilities of Carbapenemase-Producing Enterobacteriaceae Isolated in Tertiary Care Hospital in South India. J Pure Appl Microbiol. 2022;16:2488\u201395.","journal-title":"J Pure Appl Microbiol"},{"key":"4940_CR34","doi-asserted-by":"publisher","unstructured":"Cui X, Zhang H, Du H. Carbapenemases in Enterobacteriaceae: Detection and Antimicrobial Therapy. Front Microbiol. 2019;10. https:\/\/doi.org\/10.3389\/fmicb.2019.01823.","DOI":"10.3389\/fmicb.2019.01823"},{"key":"4940_CR35","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.4067\/S0034-98872004001000003","volume":"132","author":"QP D\u00edaz","year":"2004","unstructured":"D\u00edaz QP, Bello TH, Dom\u00ednguez YM, Trabal FN, Mella MS, Zemelman ZR, et al. Resistance to gentamicin, amikacin and ciprofloxacin among nosocomial isolates of Klebsiella pneumoniae subspecie pneumoniae producing extended spectrum \u00df-lactamases. Rev M\u00e9d Chile. 2004;132:1173\u20138.","journal-title":"Rev M\u00e9d Chile"},{"key":"4940_CR36","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12879-024-09248-6","volume":"24","author":"C Soria-Segarra","year":"2024","unstructured":"Soria-Segarra C, Soria-Segarra C, Molina-Matute M, Agreda-Orellana I, N\u00fa\u00f1ez-Quezada T, Cevallos-Apolo K, et al. Molecular epidemiology of carbapenem-resistant gram-negative bacilli in Ecuador. BMC Infect Dis. 2024;24:378.","journal-title":"BMC Infect Dis"},{"key":"4940_CR37","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1128\/AAC.01232-12","volume":"57","author":"J Ramirez","year":"2013","unstructured":"Ramirez J, Dartois N, Gandjini H, Yan JL, Korth-Bradley J, McGovern PC. Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia. Antimicrob Agents Chemother. 2013;57:1756\u201362.","journal-title":"Antimicrob Agents Chemother"},{"key":"4940_CR38","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s12325-020-01235-y","volume":"37","author":"L Zha","year":"2020","unstructured":"Zha L, Pan L, Guo J, French N, Villanueva EV, Tefsen B. Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis. Adv Ther. 2020;37:1049\u201364.","journal-title":"Adv Ther"},{"key":"4940_CR39","doi-asserted-by":"publisher","first-page":"14418","DOI":"10.1038\/s41598-024-65106-0","volume":"14","author":"C Li","year":"2024","unstructured":"Li C, Chen R, Qiao J, Ge H, Fang L, Liu R, et al. Distribution and molecular characterization of carbapenemase-producing gram-negative bacteria in Henan, China. Sci Rep. 2024;14:14418.","journal-title":"Sci Rep"},{"key":"4940_CR40","doi-asserted-by":"publisher","DOI":"10.33590\/emj\/10300425","author":"DN Joshi","year":"2023","unstructured":"Joshi DN, Shenoy B, B MV, Adhikary R, Shamarao S, Mahalingam A. Prevalence of Carbapenem-Resistant Enterobacteriaceae and the Genes Responsible for Carbapenemase Production in a Tertiary Care Hospital in South India. EMJ. 2023. https:\/\/doi.org\/10.33590\/emj\/10300425.","journal-title":"EMJ"},{"key":"4940_CR41","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ijmmb.2021.05.008","volume":"39","author":"S Giri","year":"2021","unstructured":"Giri S, Karade S, Sen S. Genotypic characterization of carbapenem resistant Enterobacterales in clinical isolates from western Maharashtra. Indian J Med Microbiol. 2021;39:500\u20133.","journal-title":"Indian J Med Microbiol"},{"key":"4940_CR42","unstructured":"National Institute of Public Health Research. Surveillance of ESBL and Carbapenemases in Ecuador, 2018\u20132021 period. INSPI. 2022 https:\/\/www.investigacionsalud.gob.ec\/webs\/ram\/wp-content\/uploads\/2022\/11\/2do-Boletin-CRN-Resistencia-Antimicrobiana.pdf."},{"key":"4940_CR43","doi-asserted-by":"publisher","first-page":"e17199","DOI":"10.7717\/peerj.17199","volume":"12","author":"N Sotomayor","year":"2024","unstructured":"Sotomayor N, Villacis JE, Burneo N, Reyes J, Zapata S, Bayas-Rea RL\u00c1. Carbapenemase genes in clinical and environmental isolates of Acinetobacter spp. from Quito, Ecuador. PeerJ. 2024;12:e17199.","journal-title":"PeerJ"},{"key":"4940_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4067\/S0716-10182021000200189","volume":"38","author":"M Guerra-Sarmiento","year":"2021","unstructured":"Guerra-Sarmiento M, Ru\u00edz-Martin-Leyes F, Arzuza-Ortega L, Maestre-Serrano R, Guerra-Sarmiento M, Ru\u00edz-Martin-Leyes F, et al. Characterization of multiresistant gram-negative bacilli, isolated in patients hospitalized in health institutions in Barranquilla (Colombia). Rev Chil Infectol. 2021;38:189\u201396.","journal-title":"Rev Chil Infectol"},{"key":"4940_CR45","unstructured":"Pan American Health Organization \/ World Health Organization. Epidemiological Alert: Emergence and Increase of New Combinations of Carbapenemases in Enterobacterales in Latin America and the Caribbean. PAHO \/WHO; 2021. https:\/\/www.paho.org\/sites\/default\/files\/2023-08\/2021-octubre-phe-alerta-epi-carbapenamasassp.pdf."},{"key":"4940_CR46","doi-asserted-by":"publisher","unstructured":"Wang YC, Tang HL, Liao YC, Chiou CS, Chen YT, Chiang MK, et al. Cocarriage of Distinct blaKPC-2 and blaOXA-48 Plasmids in a Single Sequence Type 11 Carbapenem-Resistant Klebsiella pneumoniae Isolate. Antimicrob Agents Chemother. 2019;63. https:\/\/doi.org\/10.1128\/aac.02282-18.","DOI":"10.1128\/aac.02282-18"},{"key":"4940_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12864-021-08214-9","volume":"23","author":"Y Yang","year":"2022","unstructured":"Yang Y, Yang Y, Ahmed MAEGES, Qin M, He R, Wu Y, et al. Carriage of distinct blaKPC-2 and blaOXA-48 plasmids in a single ST11 hypervirulent Klebsiella pneumoniae isolate in Egypt. BMC Genomics. 2022;23:20.","journal-title":"BMC Genomics"},{"key":"4940_CR48","unstructured":"Linares Flores C, Martinez Freres G, Torres Ponce A, Alc\u00edvar Murillo S, Bravo Espinoza R, Y\u00e9pez Anchundia S. Co-production of carbapenemases: in vitro challenge for microbiology laboratories, in vivo challenge for physicians. INSPILIP 2023. https:\/\/www.inspilip.gob.ec\/index.php\/inspi\/article\/view\/373."},{"key":"4940_CR49","doi-asserted-by":"publisher","first-page":"e00024","DOI":"10.1128\/mSphere.00024-19","volume":"4","author":"C Fr\u00f6hlich","year":"2019","unstructured":"Fr\u00f6hlich C, S\u00f8rum V, Thomassen AM, Johnsen PJ, Leiros HS, Samuelsen \u00d8. OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs. mSphere. 2019;4:e00024\u201319.","journal-title":"mSphere"},{"key":"4940_CR50","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3390\/antibiotics10111318","volume":"10","author":"S Palwe","year":"2021","unstructured":"Palwe S, Bakthavatchalam YD, Khobragadea K, Kharat AS, Walia K, Veeraraghavan B. In-Vitro Selection of Ceftazidime\/Avibactam Resistance in OXA-48-Like-Expressing Klebsiella pneumoniae: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of \u03b2-Lactam Plus Novel \u03b2-Lactamase Inhibitor or \u03b2-Lactam Enhancer Combinations. Antibiot (Basel). 2021;10:1318.","journal-title":"Antibiot (Basel)"},{"key":"4940_CR51","doi-asserted-by":"publisher","first-page":"107650","DOI":"10.1016\/j.ijantimicag.2025.107650","volume":"67","author":"AT Aslan","year":"2026","unstructured":"Aslan AT, Tanriverdi ES, Kaya SY, Dalgan G, Salto\u011flu N, Y\u0131lmaz E, et al. Comparison of ceftazidime-avibactam with other appropriate antimicrobial therapy for the treatment of OXA-48- or KPC-producing Enterobacterales infections in T\u00fcrkiye: A multi-centre retrospective matched-cohort study. Int J Antimicrob Agents. 2026;67:107650.","journal-title":"Int J Antimicrob Agents"},{"key":"4940_CR52","doi-asserted-by":"publisher","unstructured":"Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, et al. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. Antimicrob Agents Chemother. 2018;62. https:\/\/doi.org\/10.1128\/aac.01882-17.","DOI":"10.1128\/aac.01882-17"},{"key":"4940_CR53","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10096-018-3244-4","volume":"37","author":"T Karampatakis","year":"2018","unstructured":"Karampatakis T, Antachopoulos C, Tsakris A, Roilides E. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data. Eur J Clin Microbiol Infect Dis. 2018;37:1211\u201320.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4940_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jgar.2024.08.014","volume":"39","author":"S Alimoghadam","year":"2024","unstructured":"Alimoghadam S, Eslami A, Alimoghadam R, Bahrami Mianrood I, Azizmohammad Looha M, Khodadadi S, et al. The frequency of AmpC overproduction, OprD downregulation and OprM efflux pump expression in Pseudomonas aeruginosa: A comprehensive meta-analysis. J Glob Antimicrob Resist. 2024;39:159\u201369.","journal-title":"J Glob Antimicrob Resist"},{"key":"4940_CR55","doi-asserted-by":"crossref","unstructured":"Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12:826\u201336.","DOI":"10.1111\/j.1469-0691.2006.01456.x"},{"key":"4940_CR56","doi-asserted-by":"publisher","unstructured":"Seshatri S, Charan J, Tak V, Nag VL, Varthya SB, Ambwani S. Frequency of OXA-Type Carbapenemases among Carbapenem-Resistant Acinetobacter baumannii in Clinical Isolates from Adult Intensive Care Unit in India. J Lab Physicians. 2023. https:\/\/doi.org\/10.1055\/s-0043-1771243. https:\/\/www.thieme-connect.com\/products\/ejournals\/abstract\/","DOI":"10.1055\/s-0043-1771243"},{"key":"4940_CR57","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.chembiol.2013.07.015","volume":"20","author":"CA Smith","year":"2013","unstructured":"Smith CA, Antunes NT, Stewart NK, Toth M, Kumarasiri M, Chang M, et al. Structural Basis for Carbapenemase Activity of the OXA-23 \u03b2-Lactamase from Acinetobacter baumannii. Chem Biol. 2013;20:1107\u201315.","journal-title":"Chem Biol"},{"key":"4940_CR58","doi-asserted-by":"crossref","unstructured":"Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010; 65: 233-8. Erratum in: J Antimicrob Chemother. 2010;65:1317.","DOI":"10.1093\/jac\/dkp428"},{"issue":"Suppl 1","key":"4940_CR59","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1093\/cid\/ciad260","volume":"77","author":"CRV Kiffer","year":"2023","unstructured":"Kiffer CRV, Rezende TFT, Costa-Nobre DT, Marinonio ASS, Shiguenaga LH, Kulek DNO, et al. A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence. Clin Infect Dis. 2023;77(Suppl 1):S29\u201337.","journal-title":"Clin Infect Dis"},{"key":"4940_CR60","first-page":"101185","volume":"49","author":"M Pillonetto","year":"2025","unstructured":"Pillonetto M, Wink PL, Melano RG, Jim\u00e9nez-Pearson MA, Melgarejo Touchet NL, Saavedra Rojas SY, et al. Carbapenemases producing gram-negative bacteria surveillance in Latin America and the caribbean: a retrospective observational study from 2015 to 2020. Lancet Reg Health Am. 2025;49:101185.","journal-title":"Lancet Reg Health Am"},{"key":"4940_CR61","first-page":"123","volume":"12","author":"RS Abou-assy","year":"2023","unstructured":"Abou-assy RS, Aly MM, Amasha RH, Jastaniah S, Alammari F, Shamrani M. Carbapenem Resistance Mechanisms, Carbapenemase Genes Dissemination, and Laboratory Detection Methods: A Review. IJPRAS. 2023;12:123\u201338.","journal-title":"IJPRAS"},{"key":"4940_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijantimicag.2015.11.013","volume":"47","author":"MJ Ellington","year":"2016","unstructured":"Ellington MJ, Findlay J, Hopkins KL, Meunier D, Alvarez-Buylla A, Horner C, et al. Multicentre evaluation of a real-time PCR assay to detect genes encoding clinically relevant carbapenemases in cultured bacteria. Int J Antimicrob Agents. 2016;47:151\u20134.","journal-title":"Int J Antimicrob Agents"},{"key":"4940_CR63","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41576-023-00649-y","volume":"25","author":"SP Djordjevic","year":"2024","unstructured":"Djordjevic SP, Jarocki VM, Seemann T, Cummins ML, Watt AE, Drigo B, et al. Genomic surveillance for antimicrobial resistance: a One Health perspective. Nat Rev Genet. 2024;25:142\u201357.","journal-title":"Nat Rev Genet"},{"key":"4940_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13073-022-01020-2","volume":"14","author":"C Waddington","year":"2022","unstructured":"Waddington C, Carey ME, Boinett CJ, Higginson E, Veeraraghavan B, Baker S. Exploiting genomics to mitigate the public health impact of antimicrobial resistance. Genome Med. 2022;14:15.","journal-title":"Genome Med"},{"key":"4940_CR65","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1186\/s12864-024-10835-9","volume":"25","author":"I Mej\u00eda-Limones","year":"2024","unstructured":"Mej\u00eda-Limones I, Andrade-Molina D, Morey-Le\u00f3n G, Hidalgo-Olmedo JC, Chang-Asinc JG, Fern\u00e1ndez-Cadena JC, et al. Whole-genome sequencing of Klebsiella pneumoniae MDR circulating in a pediatric hospital setting: a comprehensive genome analysis of isolates from Guayaquil, Ecuador. BMC Genomics. 2024;25:928.","journal-title":"BMC Genomics"},{"key":"4940_CR66","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41467-022-35713-4","volume":"14","author":"NL Sherry","year":"2023","unstructured":"Sherry NL, Horan KA, Ballard SA, Gon\u04abalves da Silva A, Gorrie CL, Schultz MB, et al. An ISO-certified genomics workflow for identification and surveillance of antimicrobial resistance. Nat Commun. 2023;14:60.","journal-title":"Nat Commun"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-04940-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04940-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04940-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:03:53Z","timestamp":1777248233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-04940-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4940"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-04940-w","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the University Esp\u00edritu Santo (code 2022\u2013001\u00a0A), certified by the Ministry of Public Health of Ecuador, and conducted in accordance with the principles outlined in the Declaration of Helsinki. The requirement to obtain informed consent was waived by the same Ethics Committee (Ethics Committee of the Universidad Esp\u00edritu Santo) because the study included only isolates from a collection, the data were anonymized, and no patient information was disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"401"}}